Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 3
1975 2
1976 2
1978 1
1979 3
1980 1
1981 2
1982 2
1983 1
1984 3
1985 3
1986 1
1988 2
1990 1
1992 2
1993 3
1994 3
2002 2
2003 1
2004 1
2005 3
2008 1
2009 1
2014 2
2015 4
2016 2
2017 2
2018 2
2019 7
2020 6
2021 4
2022 3
2023 3
2024 4
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüroğlu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS; NIAGARA Investigators. Powles T, et al. N Engl J Med. 2024 Nov 14;391(19):1773-1786. doi: 10.1056/NEJMoa2408154. Epub 2024 Sep 15. N Engl J Med. 2024. PMID: 39282910 Clinical Trial.
Editorial Comment.
VanderWeele D, Hussain M. VanderWeele D, et al. J Urol. 2021 Sep;206(3):628-629. doi: 10.1097/JU.0000000000001797.01. Epub 2021 Jun 11. J Urol. 2021. PMID: 34115534 No abstract available.
NCCN Guidelines® Insights: Testicular Cancer, Version 2.2025.
Gilligan T, Lin DW, Adra N, Bagrodia A, Feldman DR, Yamoah K, Aggarwal R, Chandrasekar T, Costa D, Drakaki A, Eggener S, Emamekhoo H, Geynisman DM, Graham L, Humphrey P, Leuva H, Levine EG, Luckenbaugh A, Maughan BL, McGregor B, Monk P, Picus J, Pierorazio P, Rais-Bahrami S, Reichert Z, Rwigema JC, Saylor P, Shah A, Shah S, Singla N, Sircar K, VanderWeele D, Zhumkhawala A, Montgomery S, Sliker B. Gilligan T, et al. Among authors: vanderweele d. J Natl Compr Canc Netw. 2025 Apr;23(4):e250018. doi: 10.6004/jnccn.2025.0018. J Natl Compr Canc Netw. 2025. PMID: 40203876
EDITORIAL COMMENT.
VanderWeele DJ, Hussain M. VanderWeele DJ, et al. Urology. 2020 Dec;146:165-166. doi: 10.1016/j.urology.2020.06.114. Urology. 2020. PMID: 33272420 No abstract available.
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer.
Aggarwal RR, Vuky J, VanderWeele D, Rettig M, Heath EI, Quigley D, Huang J, Chumber A, Cheung A, Foye A, Leung S, Abbey J, Dorr A, Nasoff M, Hunter J, Wang S, Flavell RR, Fong L, Liu B, Small EJ. Aggarwal RR, et al. Among authors: vanderweele d. J Clin Oncol. 2025 May 20;43(15):1824-1834. doi: 10.1200/JCO-24-01989. Epub 2025 Mar 26. J Clin Oncol. 2025. PMID: 40138611 Clinical Trial.
Past, Current, and Future of Immunotherapies for Prostate Cancer.
Boettcher AN, Usman A, Morgans A, VanderWeele DJ, Sosman J, Wu JD. Boettcher AN, et al. Among authors: vanderweele dj. Front Oncol. 2019 Sep 11;9:884. doi: 10.3389/fonc.2019.00884. eCollection 2019. Front Oncol. 2019. PMID: 31572678 Free PMC article. Review.
84 results